Edition:
United States

ALK-Abello A/S (ALKb.CO)

ALKb.CO on Copenhagen Stock Exchange

1,000.00DKK
10:59am EDT
Change (% chg)

kr.0.00 (+0.00%)
Prev Close
kr.1,000.00
Open
kr.1,000.00
Day's High
kr.1,014.00
Day's Low
kr.1,000.00
Volume
6,835
Avg. Vol
10,627
52-wk High
kr.1,133.00
52-wk Low
kr.839.00

Select another date:

Thu, Sep 14 2017

BRIEF-Successful phase III trial for Alk's tree allergy Slit-Tablet

* Successful phase III trial for Alk's tree allergy slit-tablet

BRIEF-ALK to accelerate launches of Odactra in U.S.

* Says ‍FDA transferred U.S. product licences for slit-tablet portfolio to ALK

BRIEF-ALK-Abello Q2 EBIT loss at DKK 28 mln, higher than expected

* Q2 TOTAL REVENUE DKK ‍691​ MILLION (REUTERS POLL DKK 695 MILLION)

BRIEF-Alk-Abello CFO Flemming Pedersen to leave company

* FLEMMING PEDERSEN, CFO AND MEMBER OF BOARD OF MANAGEMENT, HAS DECIDED TO RESIGN HIS POSITION AND LEAVE ALK TO JOIN A PRIVATELY OWNED DANISH COMPANY IN ANOTHER INDUSTRY

BRIEF-Alk-Abello ‍releases analysis of data from GAP clinical trial in children​

* ALK ABELLO - ‍RELEASES FURTHER ANALYSIS OF DATA FROM FIVE-YEAR GRAZAX ASTHMA PREVENTION (GAP) CLINICAL TRIAL IN CHILDREN​

BRIEF-ALK-Abello Q1 EBITDA DKK 140 million

* Q1 TOTAL REVENUE DKK 789 MILLION VERSUS DKK 848 MILLION YEAR AGO

BRIEF-ALK-Abello: Torii submits paediatric registration application for house dust mite SLIT-tablet in Japan

* ALK’s partner, Torii, submits paediatric registration application for the house dust mite SLIT-tablet in Japan

Select another date: